Biogen ($BIIB) podcast mentions
Per Ticker.id: 2 Biogen ($BIIB) mentions across 2 podcasts (30 days) — timestamped, verifiable quotes, updated 2026-10-12.
Still ahead, shares of Biogen are moving higher after JPMorgan upgrades the stock. More details on that call after a quick break. Welcome back. Shares of Biogen are jumping today. That's after JPMorgan upgrades the stock to overweight, increases the price target to $300 per share. JPMorgan citing, quote, an increasingly compelling catalyst path and an improved long-term growth outlook for the company, which is up about 4% on the best day here since July.
Sarah Eisen · Squawk on the Street · 11AM Hour: Bank Earnings on Deck, Early Facebook Investor Roger McNamee & AI vs. Humans in Health Care 10/12/26 · 2026-10-12We mentioned some upgrades this morning. Biogen gets taken to overweight over at JPM. I got some other ones— Salesforce, T-Mobile, nice price target increase for Apple today. We'll get to all of those.
Carl Quintanilla · Squawk on the Street · 9am Hour: Bull Market Turns 4, Starbucks/Chipotle Update, AI Deals in the Works? 10/12/26 · 2026-10-12Crude oil is up 1.3% at $93 a barrel. Brent crude is up 1.4% at $106. The FTSE 100 is up 0.5% and the DAX is up 0.6%. The markets in Japan were closed for a holiday. Biogen is on our Biggest Movers list. BIIB is up 2%. Shares rose after JPMorgan upgraded the biotech company to overweight from neutral, citing an increasingly attractive pipeline of catalysts expected in 2027 and an improved long-term growth outlook. And the economic calendar looks very light today, no major events scheduled. That's it for today's Wall Street Breakfast. Thanks for listening. To take full advantage of Seeking Alpha with coverage on significant stocks and ETFs, become a premium subscriber. Check out seekingalpha.com/subscriptions.
Julie Morgan · Wall Street Breakfast · GTA 6 threat sends token up · 2026-10-12